Emergency care evidence in practice series - use of Ipratropium Bromide for acute asthma

Publication Details

Author(s):

• NHMRC (AU) - National Health and Medical Research Council

Country(ies) of application:

• Australia

Language(s):

• English

Type of Publication:

Guideline

Primary Contact:

Geraint Duggan
geraint.duggan@nhmrc.gov.au

Publication URL:

Open Publication URL in a new window

Publication Scope:

• Management

Publication Status:

Published

Date of publication:

Jan 01, 2006

Due for Review:

-

Diseases / Conditions Addressed

MeSH Terms addressed:

• Respiratory Tract Diseases (C08)
  • Lung Diseases, Obstructive (C08.381.495)
    • Asthma (MesH C08.381.495.108)
• Immune System Disorders / Immunologic Diseases (C20)
  • Allergy / Hypersensitivity (C20.543)
• Pharmacologic Actions (D27.505)
• Health Services (N02.421)
  • Emergency Medical Services (N02.421.297)

Additional Information

Use of Ipratropium Bromide for acute asthma - colour (PDF)

Use of Ipratropium bromide for acute asthma - monochrome (PDF)

Use of Ipratropium Bromide resources document (PDF)

Guideline key questions